Canagliflozin and Renal Events in Diabetes with Established Nephropathy Clinical Evaluation and Study of Diabetic Nephropathy with Atrasentan: what was learned about the treatment of diabetic kidney disease with canagliflozin and atrasentan?-Reference-Cited by-同舟云学术

Canagliflozin and Renal Events in Diabetes with Established Nephropathy Clinical Evaluation and Study of Diabetic Nephropathy with Atrasentan: what was learned about the treatment of diabetic kidney disease with canagliflozin and atrasentan?

Published:2019-05-31 Issue:3 Volume:12 Page:313-321
ISSN:2048-8513
Container-title:Clinical Kidney Journal
language:en
Short-container-title:

Author:

Fernandez-Fernandez Beatriz¹²³,Fernandez-Prado Raul¹²³,Górriz Jose Luis³⁴,Martinez-Castelao Alberto³⁵,Navarro-González Juan F³⁶,Porrini Esteban³⁷,Soler María José³⁸⁹,Ortiz Alberto¹²³

Affiliation:

1. IIS-Fundacion Jimenez Diaz UAM and School of Medicine, UAM, Madrid, Spain

2. REDINREN, Madrid, Spain

3. GEENDIAB, Barcelona, Spain

4. Hospital Clínico Universitario, Universitat de Valencia-INCLIVA, Valencia, Spain

5. Bellvitge University Hospital, Hospitalet, Barcelona, Spain

6. Unidad de Investigación y Servicio de Nefrología, Hospital Universitario Nuestra Señora de Candelaria, Santa Cruz de Tenerife, Spain

7. Instituto de Tecnologías Biomédicas, Hospital Universitario de Canarias, Universidad de La Laguna, Santa Cruz de Tenerife, Spain

8. Nephrology Department, Hospital Universitari Vall d’Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain

9. Nephrology Research Group, Vall d’Hebron Research Institute, Barcelona, Spain

Funder

FIS/Fondos FEDER